Clinical Features	Time to Death		AGE		GENDER		KARNOFSKY.PERFORMANCE.SCORE		PATHOLOGY.T		PATHOLOGY.N		PATHOLOGICSPREAD(M)		TUMOR.STAGE	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q
CDC27	4 (4%)	95	0.59803	1	0.78153	1	0.59277	1	NA	NA	0.78256	1	NA	NA	0.1293	1	0.45167	1
MET	7 (7%)	92	0.69475	1	0.87732	1	1	1	NA	NA	1	1	NA	NA	1	1	0.89209	1
IL32	4 (4%)	95	9.4369e-15	4.25e-13	0.37045	1	0.30145	1	NA	NA	0.78256	1	NA	NA	0.22165	1	0.67119	1
PCF11	7 (7%)	92	0.83383	1	0.39885	1	0.42286	1	NA	NA	0.7495	1	0.20168	1	0.5801	1	1	1
SFRS2IP	5 (5%)	94	0.22626	1	0.12149	1	0.65707	1	NA	NA	0.10743	1	1	1	0.083925	1	0.32767	1
NF2	6 (6%)	93	0.59803	1	0.13866	1	1	1	NA	NA	0.30144	1	0.058263	1	0.025168	1	0.061918	1
LGI4	4 (4%)	95	0.19047	1	0.91317	1	0.30145	1	NA	NA	0.78256	1	NA	NA	0.70662	1	0.67119	1